Thousand Oaks Biopharmaceuticals

About:

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.

Website: http://www.tobiopharm.com/

Top Investors: CICC, Hillhouse Investment, Addor Capital, CDH Investments, GL Ventures LLC

Description:

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.

Total Funding Amount:

2.2B CNY

Headquarters Location:

Haimen, Guangdong, China

Founded Date:

2017-03-01

Contact Email:

hr(AT)tobiopharm.com

Founders:

Shun Luo

Number of Employees:

501-1000

Last Funding Date:

2022-07-05

IPO Status:

Private

© 2025 bioDAO.ai